/BMK.L
BMK.L Stock - Benchmark Holdings plc
Healthcare|Drug Manufacturers - Specialty & GenericLSE
$22.05+4.01%
+$0.85 (+4.01%) • Aug 15
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.16
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $24.26
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BMK.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$21.83 – $22.27
TARGET (TP)$25.36
STOP LOSS$20.29
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.30
52W High$44.47
52W Low$16.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $90.36M | $169.48M | $158.28M | $125.06M | $105.56M |
| Gross Profit | $43.95M | $86.75M | $83.13M | $65.58M | $54.96M |
| Gross Margin | 48.6% | 51.2% | 52.5% | 52.4% | 52.1% |
| Operating Income | $-35,499,000 | $-5,316,000 | $-4,756,000 | $-1,008,000 | $-7,678,000 |
| Net Income | $-39,464,000 | $-23,146,000 | $-30,451,000 | $-11,576,000 | $-22,775,000 |
| Net Margin | -43.7% | -13.7% | -19.2% | -9.3% | -21.6% |
| EPS | $-0.05 | $-0.03 | $-0.04 | $-0.02 | $-0.04 |
Company Overview
Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge that supports the development of food and farming industries in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers salmon breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products to the aquaculture market. Benchmark Holdings plc was founded in 2000 and is based in Sheffield, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BMK.LBeat Rate
13%
Last 8 quarters
Avg Surprise
+884.0%
EPS vs Estimate
Beats / Misses
1/7
Last 12 quarters
Latest EPS
$-0.01
Q2 2025
EPS Surprise History
Q3 23
-1891.4%
$-0.01vs$-0.00
Q4 23
-176.8%
$-0.02vs$-0.01
Q1 24
-386.7%
$-0.01vs$0.00
Q2 24
-140.7%
$-0.00vs$0.00
Q3 24
-2333.3%
$-0.01vs$0.00
Q4 24
-134.8%
$-0.03vs$0.08
Q2 25
+12913.2%
$0.12vs$-0.00
Q2 25
-777.8%
$-0.01vs$-0.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 26, 2026 | — | — | — | — |
Q4 2025 | Nov 27, 2025 | — | — | — | — |
Q2 2025 | Jun 12, 2025 | $-0.00 | $-0.01 | -777.8% | ✗ MISS |
Q2 2025 | May 29, 2025 | $-0.00 | $0.12 | +12913.2% | ✓ BEAT |
Q1 2025 | Feb 28, 2025 | $0.01 | — | — | — |
Q4 2024 | Nov 27, 2024 | $0.08 | $-0.03 | -134.8% | ✗ MISS |
Q3 2024 | Aug 22, 2024 | $0.00 | $-0.01 | -2333.3% | ✗ MISS |
Q2 2024 | May 22, 2024 | $0.00 | $-0.00 | -140.7% | ✗ MISS |
Q1 2024 | Feb 15, 2024 | $0.00 | $-0.01 | -386.7% | ✗ MISS |
Q4 2023 | Nov 29, 2023 | $-0.01 | $-0.02 | -176.8% | ✗ MISS |
Q3 2023 | Aug 24, 2023 | $-0.00 | $-0.01 | -1891.4% | ✗ MISS |
Q2 2023 | May 23, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 28, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 30, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.02 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q1 2022 | Feb 22, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BMK.L
What is BMK.L's current stock price?
Benchmark Holdings plc (BMK.L) is currently trading at $22.05 per share. The stock has moved +4.01% today.
What is the analyst price target for BMK.L?
No analyst price targets are currently available for this stock.
What sector is Benchmark Holdings plc in?
Benchmark Holdings plc operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the LSE exchange.
What is BMK.L's market cap?
Benchmark Holdings plc has a market capitalization of $0.14 billion, making it a small-cap company.
Does BMK.L pay dividends?
No, Benchmark Holdings plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorARIX.L
Arix Bioscience plc
$142.00
Mkt Cap: $18.4B
CEL.L
Celadon Pharmaceuticals Plc
$13.40
Mkt Cap: $0.9B
CNSL.L
Cambridge Nutritional Sciences plc
$1.95
Mkt Cap: $0.5B
ETX.L
E-therapeutics Plc
$9.00
Mkt Cap: $5.6B
INS.L
Instem plc
$829.00
Mkt Cap: $19.9B
MXC.L
MGC Pharmaceuticals Limited
$21.20
Mkt Cap: $0.9B
MXCT.L
MaxCyte, Inc.
$147.69
Mkt Cap: $15.7B
REDX.L
Redx Pharma Plc
$15.00
Mkt Cap: $5.8B
RGT.L
Argent BioPharma Limited
$6.00
Mkt Cap: $0.4B
SMD.L
Spectral MD Holdings, Ltd.
$58.00
Mkt Cap: $8.0B
Explore stocks similar to BMK.L for comparison